SCHEMBL677848

SCHEMBL677848

CC(=O)c1ccc(C(C)[Sb](C)C)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.48
HPGD P15428 4/20 0.48
RAB9A P51151 3/20 0.48
LMNA P02545 3/20 0.43
L3MBTL1 Q9Y468 2/20 0.43
KMT2A Q03164 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.42
HSD17B1 P14061 1/20 0.42
MAPK1 P28482 3/20 0.39
NOS3 P29474 2/20 0.39
NOS1 P29475 2/20 0.39
POLB P06746 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
NPC1 O15118 2/20 0.38
ALDH1A1 P00352 1/20 0.38
STAT3 P40763 1/20 0.38
STAT1 P42224 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
OPRD1 P41143 1/20 0.38
KCNJ1 P48048 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20448417 0.79 ESR1 (0.35)
SCHEMBL677916 0.79 ALDH1A1 (0.52) MAPTHPGDRAB9ALMNAL3MBTL1
SCHEMBL677797 0.79 CA1 (0.52) MAPTRAB9AL3MBTL1KMT2ANPC1
SCHEMBL182327 0.78 CYP2C9 (0.55) MAPTHPGDRAB9ALMNAL3MBTL1
SCHEMBL9683939 0.78 MAPT (0.50) MAPTHPGDRAB9ALMNAL3MBTL1
Hydrochloric Acid SCHEMBL5197216 0.76 CYP2C9 (0.53) MAPTHPGDRAB9ALMNAL3MBTL1
SCHEMBL1262317 0.76 MAPT (0.48) MAPTHPGDRAB9ALMNAL3MBTL1
SCHEMBL17319344 0.76 MAPT (0.48) MAPTHPGDRAB9ALMNAL3MBTL1
SCHEMBL16659380 0.75 MAPT (0.52) MAPTHPGDRAB9ALMNAL3MBTL1
SCHEMBL4797264 0.74 ROCK2 (0.50) MAPTHPGDRAB9ALMNAL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110275774-A1 ORGANOANTIMONY COMPOUND, PROCESS FOR PREPARING SAME, LIVING RADICAL POLYMERIZATION INITIATOR, PROCESS FOR PRODUCING POLYMER WITH USE OF SAME, AND THE POLYMER YAMAGO SHIGERU 2011-11-10 US disclosed
US-8008414-B2 Organic antimony compound, process for producing the same, living radical polymerization initiator, process for producing polymer using the same, and polymer OTSUKA CHEMICAL CO., LTD. (JP) 2011-08-30 US disclosed
EP-1767539-B1 ORGANIC ANTIMONY COMPOUND, PROCESS FOR PRODUCING THE SAME, LIVING RADICAL POLYMERIZATION INITIATOR, PROCESS FOR PRODUCING POLYMER USING THE SAME, AND POLYMER OTSUKA CHEMICAL CO LTD (JP) 2011-07-27 EP disclosed
US-20090299008-A1 Organic antimony compound, process for producing the same, living radical polymerization initiator, process for producing polymer using the same, and polymer OTSUKA CHEMICAL CO., LTD. (JP) 2009-12-03 US disclosed
EP-1767539-A1 ORGANIC ANTIMONY COMPOUND, PROCESS FOR PRODUCING THE SAME, LIVING RADICAL POLYMERIZATION INITIATOR, PROCESS FOR PRODUCING POLYMER USING THE SAME, AND POLYMER OTSUKA CHEMICAL COMPANY, LTD. (JP) 2007-03-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090299008-A1 Organic antimony compound, process for producing the same, living radical polymerization initiator, process for producing polymer using the same, and polymer AOC2, ODC1, MCM7 MAPT 2424/4885HPGD 4098/4885RAB9A 4268/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.